Balyasny Asset Management
PRVB

Balyasny Asset Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Balyasny Asset Management’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-588,758
Closed -$14.2M – 2683
2023
Q1 		$14.2M Buy
+588,758
New +$14.2M 0.04% 509